MOTS-C is typically run in cycles (812 weeks on, 4 weeks off) to prevent receptor downregulation, though some people run it continuously at lower doses
Call us at 707-579-1102 or book your appointment online to get started
BPC-157 works in the body through proposed repair pathways that involve blood vessel growth, cell movement, inflammation control, and tissue-protective signaling, but most evidence comes from animal and laboratory studies rather than confirmed human trials
FOXO4-DRI is currently explored in research focused on cellular aging, tissue rejuvenation, vascular health, and regenerative biology
Clinical and Experimental Immunology, 172 (2), 148157
It helps start the wound-healing process, draws in immune cells that protect our body (like a security team), and assists in reducing swelling